Acute Ischemic Stroke as Complication in COVID-19 with Acute Respiratory Distress Syndrome in Intensive Care Unit: A Review

Anak Agung Ayu Putri Laksmidewi; Prysta Sitanggang

doi:10.3889/oamjms.2020.5556

Authors

Anak Agung Ayu Putri Laksmidewi Department of Neurology, Medical Faculty of Udayana University, Sanglah Hospital, Bali, Indonesia
Prysta Aderlia Sitanggang Department of Neurology, Medical Faculty of Udayana University, Sanglah Hospital, Bali, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5556

Keywords:

Coronavirus disease 2019, Ischemic stroke, Acute respiratory distress syndrome, Intensive care unit

Abstract

Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has broad spectrum of manifestation ranging from asymptomatic cases to multi-organs failures. Cerebrovascular disease COVID-19 patients are still a big issue among neurologist. Neurologic manifestations are shown to be the first or late presentation in patients with SARS-CoV-2 infection. Ischemic stroke had happened majority than hemorrhage stroke in patients hospitalized with severe COVID-19 and comorbid such as hypertension, diabetes mellitus, or cardiovascular disease. Acute respiratory distress syndrome is predictable complication of COVID-19 that will ended with prolonged hospitalization and comprehensive management in intensive care unit (ICU). Anticoagulant is believed to have proven advantage to prevent this thrombogenesis. Patients with acute ischemic stroke as COVID-19 have poorer prognosis. Managing patients with ischemic stroke within the ICU are challenging due to prior use of anticoagulant as preventive of thrombosis that increase the risk of intracranial hemorrhage.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Coronavirus (COVID-19) Data. Geneva: World Health Organization; 2020. Available from: https://www.who.int/data#reports. [Last accessed on 2020 Sep 10].

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. PMid:31978945

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133(9):1025-31. https://doi.org/10.1097/cm9.0000000000000744 PMid:32044814

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585 PMid:32031570

Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80(4):388-93. https://doi.org/10.1016/j.jinf.2020.02.016 PMid:32112884

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical and mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;81(2):e16-25. https://doi.org/10.1016/j.jinf.2020.04.021 PMid:32335169

Herman C, Mayer K, Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID- 19. Neurology. 2020;95(2):77-84. https://doi.org/10.1212/ wnl.0000000000009673 PMid:32345728

Cerasti D, Ormitti F, Pardatscher S, Malchiodi L, Picetti E, Menozzi R, et al. Multiple acute ischemic strokes in a COVID- 19 patient: A case report. SN Compr Clin Med. 2020;2020:1-5. https://doi.org/10.1007/s42399-020-00388-9 PMid:32838158

Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115-9. https://doi.org/10.1016/j.bbi.2020.04.077 PMid:32360439

Marone EM, Rinaldi LF. Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations. J Vasc Surg Venous Lymphat Disord. 2020;8(4):694-5. https://doi.org/10.1016/j.jvsv.2020.04.004 PMid:32305586

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. https://doi.org/10.1001/jamacardio.2020.1017 PMid:32219356

Tal S, Spectre G, Kornowski R, Perl L. Venous thromboembolism complicated with COVID-19: What do we know so far? Acta Haematol. 2020;143(5):417-24. https://doi.org/10.1159/000508233 PMid:32396903

Tsivgoulis G, Katsanos AH, Ornello R, Sacco S. Ischemic stroke epidemiology during the COVID-19 pandemic: Navigating uncharted waters with changing tides. Stroke. 2020;51(7):1924- 6. https://doi.org/10.1161/strokeaha.120.030791 PMid:32496937

Katz JM, Libman RB, Wang JJ, Sanelli P, Filippi CG, Gribko M, et al. Cerebrovascular complications of COVID-19. Stroke. 2020;51(9):e227-31. PMid:32757751

Duroi I, Van Durme F, Bruyns T, Louage S, Heyse A. Fatal ischaemic stroke during COVID-19 and acute lung injury. Eur J Case Rep Intern Med. 2020;7(6):001732. PMid:32523931

Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020;194:101-15. https://doi.org/10.1016/j.thromres.2020.11.012 PMid:32788101

Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. Characteristics and outcomes in patients with COVID- 19 and acute ischemic stroke: The global COVID-19 stroke registry. Stroke. 2020;51(9):e254-8. https://doi.org/10.1161/strokeaha.120.031173 PMid:32787707

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez- Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera- Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. https://doi.org/10.1016/j.tmaid.2020.101623 PMid:32179124

Dewi VT, Agung A, Putri AY, Sudiariani KA. Clinical manifestation and pathogenesis of nervous system involvement in severe acute respiratory syndrome coronavirus-2 infection. Asian J Pharm Clin Res. 2020;13(10):39006. https://doi.org/10.22159/ajpcr.2020.v13i10.39006

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/ s0140-6736(20)30211-7 PMid:32007143

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43. https://doi.org/10.1001/jamainternmed.2020.0994 PMid:32167524

Li X, Ma X. Acute respiratory failure in COVID-19: Is it “typical” ARDS? Crit Care. 2020;24(1):198. https://doi.org/10.1186/s13054-020-02911-9 PMid:32375845

Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): Clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-6.e1. https://doi.org/10.5694/mja2.50674 PMid:32572965

ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell R, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012;307(23):2526-33. https://doi.org/10.1001/2012.jama.11901 PMid:22797452

Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost. 2020;120(6):998-1000. https://doi.org/10.1055/s-0040-1710018 PMid:32316063

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7. https://doi.org/10.1111/jth.14768 PMid:32073213

Okamoto K, Tamura T, Sawatsubashi Y. Sepsis and disseminated intravascular coagulation. J Intensive Care. 2016;4(23):1-8. https://doi.org/10.1186/s40560-016-0149-0

Yaghi S, Ishida K, Torres J, Grory BM, Raz E, Humbert K, et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke. 2020;51(7):2002-11. https://doi.org/10.1161/strokeaha.120.031606 PMid:32432996

Qin C, Zhou L, Hu Z, Yang S, Zhang S, Chen M, et al. Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China. Stroke. 2020;51(7):2219-23. https://doi.org/10.1161/strokeaha.120.030365 PMid:32466735

Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103-9. https://doi.org/10.1111/jth.14975 PMid:32558075

Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54-67. https://doi.org/10.1007/s11239-020-02134-3 PMid:32415579

Spence JD, de Freitas GR, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, et al. Mechanisms of stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-8. https://doi.org/10.1159/000509581 PMid:32690850

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. https://doi.org/10.1016/s0140-6736(20)30937-5 PMid:32325026

Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017;117(3):437-44. https://doi.org/10.1160/th16-08-0620 PMid:27975101

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute Ischemic stroke: 2019 Update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-418. https://doi.org/10.1161/str.0000000000000215 PMid:31662037

Qureshi AI, Abd-Allah F, Al-Senani F, Aytac E, Borhani- Haghighi A, Ciccone A, et al. Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel. Int J Stroke. 2020;15(5):540-54. https://doi.org/10.1177/1747493020923234 PMid:32362244

Co CO, Yu JR, Laxamana LC, David-Ona DI. Intravenous thrombolysis for stroke in a COVID-19 positive filipino patient, a case report. J Clin Neurosci. 2020;77:234-6. https://doi.org/10.1016/j.jocn.2020.05.006 PMid:32414622

Dogra S, Jain R, Cao M, Bilaloglu S, Zagzag D, Hochman S, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis. 2020;29(8):104984. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104984 PMid:32689588

Wang Y, Ao G, Qi X, Zeng J. The influence of corticosteroid on patients with COVID-19 infection: A meta-analysis. Am J Emerg Med. 2020;S0735-6757(20)30528-3. PMid:32616373

Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, et al. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. Clin Infect Dis. 2020;71(16):2114-20. https://doi.org/10.1101/2020.05.04.20074609 PMid:32427279

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell Jl, et al. Dexamethasone in hospitalized patients with Covid-19 preliminary report. N Engl J Med. 2020;2020:NEJMoa2021436. https://doi.org/10.1056/ nejmoa2021436 PMid:32678530